Français Néerlandais Japonais Chinois Allemand Espagnol Portugais

Nord France InvestContact 

Major innovation in fight against pleural cancer

05 Apr 2016 | Health Nutrition, A region on the move

Lille hospital plays a key role in new treatment for pleural cancer.

Healthcare innovation in Northern France

For over 10 years, medicine had made no progress in treating cancer of the pleura, the membrane lining the lungs.

But now the Bio-MAPS program, launched by Dr. Gérard Zalcman in close cooperation with 70 French hospital groups, has shown that Bevacizumab is effective in treating pleural cancer, significantly reducing mortality risk in 23% of patients who were treated with it.

Dr. Arnaud Scherpereel, head of pulmonology and thoracic oncology at Lille University Hospital Center (CHRU) and coordinator of the Bevacizumab project, stresses that the treatment is equally effective in all patient sub-groups, including those with the worst prognosis factors.

As a result, this new treatment solution is becoming the first-line therapy for patients with pleural cancer.

Back to news

News

Hauts-de-France ranked France’s 2nd-most attractive region in 2018

Once again, Hauts-de-France took high honors for foreign direct investment, ranking No. 2 in France for jobs and No. 1 for industrial projects. Learn more about our region’s attractiveness for business from...

Procter & Gamble’s latest investment in Amiens

After a global investment of €300M in five years, P&G is reinjecting €50M into its Amiens site. Read about the regional assets that convinced the leading multinational consumer goods company to invest...

All news